Review Article
Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies
Table 1
Full results of the case study screen organized by reporter and monoclonal antibody.
| Reporter | Monoclonal Antibody | Cutaneous Adverse Effect |
| Rauer et. al. | Daclizumab | DRESS syndrome |
| | Daclizumab | DRESS syndrome |
| Naidoo et. al. | Nivolumab | Drug-induced hypersensitivity dermatitis |
| | Ipilimumab/Nivolumab | Maculopapular rash, vesicles, erosions |
| | Ipilimumab/Durvalumab | Lichenoid dermatitis, blisters, exanthema |
| Fontecilla et. al. | Durvalumab/Tremelimumab | Epidermal necrolysis, eosinophilic infiltrate |
| Oiwa et. al. | Ixekizumab | Psoriasiform eruptions |
| Anthony et. al. | Ixekizumab | Pruritic, photosensitive plaques |
| Maria et. al. | Ixekizumab | Lentiginous eruption |
| Hayashida et. al. | Secukinumab | Pemphigus vulgaris |
| Thompson et. al. | Secukinumab | Ulcerative lichenoid mucositis |
| Al Hammadi & Parmar | Dupilumab | Erythema, pruritus and diffuse skin peeling |
| Takahashi et. al. | Brodalumab | Palmar pustular eruption |
|
|